One of the defects in using a fixed FF is that it does not fully account for the triglyceride contributions from lipoproteins other than VLDL. In this regard, method E represents a more rational approach. In the high-PC group we expect a higher contribution to the serum TO from LDLS, and so the FF tends to overestimate VLDL-C. It can be seen from Figure 1 that method E has shifted the frequency-distribution curve upward, whereas the remaining methods have given superimposed curves at lower LDL-C values, which demonstrates the effectiveness of method E in correcting for the contributions to TO from LDLa.
One of the defects in using a fixed FF is that it does not fully account for the triglyceride contributions from lipoproteins other than VLDL. In this regard, method E represents a more rational approach. In the high-PC group we expect a higher contribution to the serum TO from LDLS, and so the FF tends to overestimate VLDL-C. It can be seen from Figure 1 that method E has shifted the frequency-distribution curve upward, whereas the remaining methods have given superimposed curves at lower LDL-C values, which demonstrates the effectiveness of method E in correcting for the contributions to TO from LDLa.
We found that the triglyceride/cholesterol ratio for the VLDL correlated significantly with VLDL-C and HDL-C. We extended method E to include in the formula the partial regression coefficients and the intercept from multiple regression of triglyceride/cholesterol ratio in VLDL with VLDL-C and HDL-C as independent variables, but there was no improvement in the correlation of the LDL-C values so obtained with the reference LDL-C values, and the formula became too complex.
Only 13 of our patients had serum TO values exceeding 4.5 nunol/L, and so it is difficult to determine from this study up to what serum TO concentration could method E be used effectively. However, difficulty in accurate determination of Hl)L-C in the routine laboratory when PG concentrations are high is common to all the calculation methods.
Calculation of LDL-C rather than its direct determination has the advantage of saving both cost and technician time and shortening the turnaround time. We believe that meth-
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od E is a simple, rational method that is an improvement over the existing calculation methods. However, variable triglyceride/cholesterol ratios in the lipoprotein fractions and contribution to the serum lipids from lipoproteins other than HDL, LDL, and VLDL remain as sources of error.
fluids such as cerebrospinal, pleural, peritoneal, gastric, duodenal, vitreous humor, and synovial fluid represent a numerically insignificant proportion of the total number of specimens submitted to the laboratory. However, the chemical analysis of these body fluids may have important diagnostic significance (1) (2) (3) (4) . it is therefore desirable for clinical laboratories to have at their disposal precise and accurate analytical methods for chemical determinations on a wide spectrum of specimen types. The continuing reliance of clinical laboratories on commercial products has compounded the situation described over a decade ago (5) . Little documentation of performance characteristics, empirical or assumed, exists for body fluids other than blood or urine.
The introduction of dry-reagent slide-film methods of chemical analysis in the Kodak Ektachem series of analyzers (6-B) and the potential widespread use of this technology in clinical laboratories [-9% of respondents to CAP Comprehensive of Survey set C-D in 1986 used slide film technology for chemical analysis (9) ] stimulated our interest in evaluating the applicability of such methods for the analysis of all clinically relevant fluid types. Also, we wanted to investigate the effect of the diversified matrices of body fluids on the accuracy of the results on slides calibrated with a serum-based matrix. In this study, comparisons were made to "wet chemistry" methods, where the specimen is diluted with the reagent. The magnitude of the dilution should eliminate the influence of the matrix of the specimen. Of the procedures available for use with the Ektachem analyzer only a few have documented or implied applicability (10, 11) or protocols for use with body fluids other than blood, and then only with cerebrospinal fluid or urine. The analytes studied were based on the chemistry menu for the Ektachem 400 that was in use in our laboratory. We calibrated the Ektachem 400 analyzer according to the manufacturer's recommendation, using calibrators supplied by Kodak. Kodak's ammonia blank creatimne procedure was used in this study. The Encore centrifugal analyzer was calibrated with CHEM-CAL serum-based chemistry calibrator (product no-27-017-821-020; Baker Instruments). Reagents and aqueous calibration standards for the System E4-A electrolyte analyzer were obtained from Beckman Instruments, Brea, CA 92621. All other chemicals used were of analytical grade and were obtained from various commercial sources. Calibrations were verified by using multiple concentrations of assayed serum controls. Monitrol Unassayed Level I and U (lots XLS-47 and XPS 138; American Dade, Miami, FL 33152) were used as run controls during the assays with all instruments used in the study. All assays were monitored by a previously described quality-control system (13).
Materials and Methods

Human
The pleural, pericardial, synovial, and cerebrospinal fluids used in the study were patients' samples submitted to the chemistry laboratory for chemical analysis. A few pleural and pericardial fluids were obtained from the autopsy service, as were the vitreous fluids used in the study. The specimens were stored refrigerated at 4-10 #{176}C for no longer than three days before analysis. Thrbid, hemolyzed, or icteric specimens were not included in the study.
Simulated body fluid samples spanning a pH range of 2 to 9 and a protein content range of 0 to 88 g/L were prepared as follows:
1. Preparation of stock physiological solution: An aqueous stock solution containing normal physiological concentrations of glucose, urea, creatinine, sodium, potassium, chloride, bicarbonate, calcium, phosphorus, and uric acid was prepared. A clear, pale-yellow solution with an osmolality of 297 mOsmlkg was obtained. Three lots of stock solution preparations were made and used for preparing a quintuplicate of protein-modified and pH-adjusted simulated bodyfluid specimens.
Preparation of protein-modified and pH-adjusted
solutions: Five 10-mL (total volume) groups, each containing 0, 10, 25, 50, and 88 g of albumin per liter, respectively, were prepared by combining appropriate amounts of the stock physiological solution and the 250 g/L albumin preparation. Each group contained a series of eight samples whose pH was adjusted to 2.0, 3.0, 4.0, 5.0, 6.0, 7.0, 8.0, and 9.0, respectively.
The study proceeded as follows: All specimens were subjected to chemical analysis in the Ektachem 400 (used in the serum mode), the Encore centrifugal, and Beckman System E4-A electrolyte analyzers. For simulated body-fluid specimens, analyses were done promptly on the same day the protein and pH modifications were made, to avoid gelational deterioration on storage. Criteria for assessing significant differences of single assay values between the Kodak (BK) and comparative methods (CM; Encore or E4-A) were based on the use of standard deviation estimates derived from 20 run-to-run replicates on control sera.2 A significant difference was considered to be one exceeding two standard deviations of the difference, which was calculated as: . By use of these criteria as though the specimens were serum, a significant difference between single determinations was considered to be greater than 1.4 x CUL. 1 CUL = 0.25 x the normal range interval for serum, and is stated as equivalent to the least acceptable 2 SD for the technical variability of the analyte under consideration. Similarly, we evaluated the mean of the five grouped determinations for significant difference, using the analognus criteria estimate, which is equivalent to 0.6 CUL.
Results
The effects of protein and pH on selected Ektachem 400 chemistries for simulated body fluids were estimated by the preparation of an information matrix with pH on the horizontal axis from 2.0 to 9.0 at 1-pH-unit intervals and with protein concentrations along the vertical axis of 0,10, 25, 50, and 88 g/L. This matrix is illustrated for glucose in Table 1 . Based on the analysis of the findings, the glucose performance of the Ektachem was considered adequate for clinical applications on samples with a pH range of 6-8, irrespective of the protein concentration. Several other Ektachem procedures were judged to give clinically acceptable results irrespective of protein content. These findings are summarized in Table 2 . Our studies using the simulated body-fluid specimens indicate that Ektachem procedures are potentially applicable to a wide variety of specimens. However, there appears to be a bias of about 10 mmol/L between the Ektachem 400 and the Beckman EA-4 analyzer for chloride; the lower values occurred with the Ektachem 400. Both methods were influenced by changes in pH and protein content. The total carbon dioxide studies were complicated by the acidification of the specimens when adjusting the pH. However, the Ektachem results for CO2 for specimens with a pH of 7.0 gave acceptable comparisons with the Beckman EA-4 analyzer, irrespective of protein content.
To study the applicability of the Ektachem 400 analyzer for the analysis of actual miscellaneous body fluids, a total of 52 patients' specimens consisting of 22 pleural fluids, four vitreous humors, four synovial fluids, six peritoneal fluids, two pericardial fluids, and 16 cerebrospinal fluids were analyzed for all the same assays studied with the simulatedfluids system. In addition, the protein concentration of each specimen was determined with a TS meter (American Optical), biuret method, or by turbidimetry using sulfosalicylic acid precipitation, depending on the concentration. The range of protein was from 0.1 to 60 g/L. Patients' specimens were assayed in the Ektachem in the serum mode as the test method, and the Encore centrifugal analyzer and Beckman E4-A electrolyte analyzer as comparative methods.
The data obtained with each type of assay for all the bodyfluid specimens were subjected to regression analysis by the Deming procedure (15). The method-comparison plots of the data obtained for the chemistries investigated are shown in the accompanying figures.
Glucose. The heterogeneous mix of body fluids assayed in the Ektachem 400 analyzer for glucose gave values that ranged from 1.6 to 11.0 mniol/L and 1.6 to 10.6 mmolJL for the comparative method as shown in Figure IA 
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difference between paired determinations with the two 6-8 methods ranged from -3.9 to +2.1 mmol/L, the mean being 6-9 -0.7 mmol/L. Over 80% of the samples gave urea values that were within 2 SD of the two methods, whereas 95% were within CUL specifications (1.4 CUL = ±2.1 mmol/L). These findings and the simulation study findings lead us to consider the Ektachem urea assay as applicable to all the body fluid types studied.
Uric acid values ( Figure 1C ) ranged from 0.30 to 7.06 mmol/L (BK) and 0.18 to 5.98 mmoIJL (CM). Differences between the two methods ranged from -0.9 to + 1.08 mniol/L. Although about 70% of the differences were within the statistical limits of the methods, about 90% were within CUL limits. Two pleural-fluid specimens and onejoint-fluid specimen gave aberrant values. We have not determined the reason(s) for this observation and we plan to evaluate additional pleural and joint fluids.
Creatinine studies gave values that ranged from 9 to 248 pmol/L (EK) and 18 to 274 pmol/L (CM), as shown in Figure  1D . The differences ranged from -35 to +27 imol/L. Approximately 95% of the samples gave differences that were within both 2 SDd and CUL requirements. All the fluid types assayed acceptably.
Cakium studies with the Ektachem 400 and the comparative method gave values that ranged from 1.1 to 3.4 mmol/L and 1.0 to 3.6 mmol/L, respectively ( Figure 1E ). The differences ranged from -02 to +0.7 mmol/L. The largest differences were seen with joint-fluid specimens that had protein concentrations of 30 g/L. These specimens had differences of + 0.6, + 0.7, and +0.7 mmol/L. About 56% of the specimens had differences that were within the statistical limits of the methods used, whereas >70% were within CUL limits. A group of pleural-fluid specimens gave differences exceeding 0.3 mmol/L, for reasons unknown. Our findings with patients' specimens and the data generated with simulation demonstrate the applicability of the Ektachem calcium method for all fluid types. The performance characteristics should be adequate for clinical utility.
Phosphorus values ( Figure 1F ) ranged from 0.3 to 4.4 nunoJ/L (EK) and 0.2 to 4.4 mmol/L (CM). About 80% of the specimens gave differences within the statistical limits of the methods, whereas the differences for >90% were within CUL specifications. The magnitude of the differences seen with joint fluids indicated some erratic results, with the Figure 2A) . Differences in the values obtained between the methods ranged from -8 to +8 mmol/L. Using the statistics of the method to evaluate the differences showed that 10% of the specimens gave statistically significant differences. The findings in this study, along with the simulated specimen findings, suggest that the Ektachem sodium method could be applied to the miscellaneous body fluids studied for the acquisition of clinically relevant data.
Potassium results for body fluids are shown in Figure 2B Figure 2D ). Differences between the values ranged from -6 to +9 mmollL. On the basis of the statistical limits of the methods, the difference for 71% of the specimens between the test and comparative method was acceptable. Six of 21 pleural-fluid specimens had unacceptable differences, close to two times the limit. The vitreousfluid specimens gave unacceptable differences, as did 50% of the joint and peritoneal fluids-but, given the number of these fluids included in the study, the observed differences may not be statistically valid. Of the spinal fluids assayed, one specimen gave an unacceptable difference.
DiscussIon
We used the Ektachem 400 analyzer to assay a series of test solutions prepared to simulate body-fluid specimens and to determine its specimen-related versatility for a set of assays currently available on the system. For most of the assays we investigated, the Ektachem showed promise of wide applicability. Certain assays proved more rugged than others with respect to variations in sample pH and protein content. Clinically relevant specimens are more likely to show variability in protein than in pH, so the demonstration of a lack of protein effect for most of assays is important. For eight of the 10 types of assay we studied, there was a lack of protein effect, and it was verified by our findings with patients' specimens. Using the simulated specimens, the Ektachem glucose results suggested a slight protein-dependent negative bias at pH 7.0. With patients' specimens this was not the case. The converse was true for the chloride assay.
This study illustrates the use of simulated specimens to assessthe potential applicability of analytical methods to a variety of patient specimens. The selection of analytes and patients' specimens investigated in this study was limited to those available in our laboratory during the study.
The performance characteristic of the Ektachem for the different fluid types is promising. Two fluid types, pleural and joint, produced enough aberrant results to warrant caution in applying the Ektachem to them. More detailed studies to assessand document performance characteristics for these and additional analytes in all the fluid types are in progress.
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